Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

RECOMBINANT MURINE PNEUMONIA VIRUS EXPRESSING SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE PROTEIN

  • Read more about RECOMBINANT MURINE PNEUMONIA VIRUS EXPRESSING SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE PROTEIN
Patent Cooperation Treaty
PCT/US2024/029917
Filed on 2024-05-17

VACCINE FOR CATS TO BLOCK TOXOPLASMA OOCYST SHEDDING AND TRANSMISSION

  • Read more about VACCINE FOR CATS TO BLOCK TOXOPLASMA OOCYST SHEDDING AND TRANSMISSION
Patent Cooperation Treaty
PCT/US2024/032292
Filed on 2024-06-03

EXPRESSION OF THE SPIKE S GLYCOPROTEIN OF SARS-COV-2 FROM AVIAN PARAMYXOVIRUS TYPE 3 (APMV3)

  • Read more about EXPRESSION OF THE SPIKE S GLYCOPROTEIN OF SARS-COV-2 FROM AVIAN PARAMYXOVIRUS TYPE 3 (APMV3)
US Application 18/710,343
Filed on 2024-05-15

HUMAN MONOCLONAL ANTIBODIES THAT TARGET THE RH5 COMPLEX OF BLOOD-STAGE PLASMODIUM FALCIPARUM

  • Read more about HUMAN MONOCLONAL ANTIBODIES THAT TARGET THE RH5 COMPLEX OF BLOOD-STAGE PLASMODIUM FALCIPARUM
Patent Cooperation Treaty
PCT/US2024/030637
Filed on 2024-05-22

Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection

  • Read more about Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection
Hong Kong
42024088832.1
Filed on 2024-03-15

SARS-COV-2 SPIKE FUSED TO HEPATITIS B SURFACE ANTIGEN

  • Read more about SARS-COV-2 SPIKE FUSED TO HEPATITIS B SURFACE ANTIGEN
US Application 18/709,441
Filed on 2024-05-10

NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE

  • Read more about NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE
US Application 18/707,305
Filed on 2024-05-03

HIV-1 ENVELOPE TRIPLE TANDEM TRIMERS AND THEIR USE

  • Read more about HIV-1 ENVELOPE TRIPLE TANDEM TRIMERS AND THEIR USE
Patent Cooperation Treaty
PCT/US2024/031661
Filed on 2024-05-30

LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF DISEASE

  • Read more about LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF DISEASE
US Application 18/288,358
Filed on 2023-10-25

LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF DISEASE

  • Read more about LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF DISEASE
China
202280037491.X
Filed on 2022-04-26

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 112
  • Page 113
  • Page 114
  • Page 115
  • Page 116
  • Page 117
  • Page 118
  • Page 119
  • Page 120
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health